Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Author(s): Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
Issue: Jan/Feb 2006 - Sports Medicine
View All Articles in Issue
Page(s): 74-78
Download in electronic PDF format for $75
Abstract: The objective of this study was to evaluate the stability of two phenytoin sodium suspensions in 0.9% sodium chloride solution for use in noninstitutional settings (where pharmacies are not present) to dispense phenytoin on a daily basis. A generic extended phenytoin sodium (Mylan) and a name brand phenytoin sodium (Dilantin) in suspension form were evaluated. Both suspensions were first assessed for degradation during frozen storage at designated time intervals. Frozen samples were compared with freshly prepared samples. The chemical stability of phenytoin concentrations in the samples was assessed by using a high-performance liquid chromatography analytical technique. During the course of the experiment, the samples showed no crystallization and the pH remained in a range of 10.6 to 10.73. The suspensions were tested for contamination. The results show that Dilantin and Mylan suspensions remained stable and free of contamination. Suspensions of phenytoin sodium in 0.9% sodium chloride solution are stable at room temperature for at least 2 weeks.
Related Keywords:
phenytoin sodium, suspensions, topical preparation, wound healing, stability, pressure ulcers, decubitus ulcers
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
|
Jan/Feb 2006
Pg. 74-78
|
Options in Wound Care
Kincaid Michele R
|
Mar/Apr 2002
Pg. 92-95
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Phenytoin Sodium 20-mg/mL Topical Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 333
|
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
|
May/Jun 2009
Pg. 196-213
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 301
|
Compounding with Sucralfate for the Treatment of External Wounds
Wynn Tom, Williams LaVonn A
|
Jan/Feb 2009
Pg. 25-29
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
|
May/Jun 2003
Pg. 176-178
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 501-508
|
Sensitization Therapy for Warts
Kuntz Rachael
|
Jul/Aug 2003
Pg. 266-270
|
Current Topical Treatments in Wound Healing - Part 2
Helmke Christopher D
|
Sep/Oct 2004
Pg. 354-357
|
Return to Top |